Literature DB >> 28966687

Screening of differentially expressed genes associated with Kawasaki disease by microarray analysis.

Jie Jiang1, Yi Cai2, Zhuoying Li1, Lihua Huang3, Jia Chen1, Lang Tian1, Zhixiang Wu1, Xin Li1, Zhiheng Chen1, Chunyuan Chen1, Zuocheng Yang1.   

Abstract

Kawasaki disease (KD) is an autoimmune disorder that can induce coronary artery aneurysms, particularly in the case of delayed diagnosis and/or treatment. Early diagnosis is important for treatment and reduces the risk of heart injury. The aim of the present study was to identify differentially expressed genes by comparing the levels of gene expression in human umbilical vein endothelial cells following treatment with plasma from healthy individuals and patients with acute or convalescent KD. Following comparison of the control and acute KD groups, 385 up-regulated and 537 down-regulated genes were identified in the acute KD group. In the convalescent group, 505 and 879 genes were up-regulated and down-regulated, respectively, relative to the control group. Genes involved in the immune system and cell growth factors were up-regulated, while genes functioning in methylation were down-regulated, following treatment with KD plasma. In addition, five potential candidate molecular markers of KD, C-X-C motif chemokine ligand 2 (CXCL2), interleukin (IL) 8, tripartite motif containing 58 (TRIM58), immunoglobulin superfamily member 3 (IGSF3) and runt related transcription factor 1 (RUNX1) were identified by microarray analysis and verified using quantitative polymerase chain reaction. A significant positive correlation was identified between the neutrophil polys and expression levels of four of these candidate genes, including CXCL2, IL8, TRIM58, and IGSF3 (all P<0.01; R2≥0.64). However, only CXCL2 expression was significantly positively correlated with neutrophil polys (P=0.01; R2=0.64) and neutrophil bands (P<0.001; R2=0.73). These results indicate that CXCL2 serves a crucial role in the injury of endothelial cells by KD plasma.

Entities:  

Keywords:  C-X-C motif chemokine ligand 2; Kawasaki disease; gene expression; microarray analysis; neutrophil

Year:  2017        PMID: 28966687      PMCID: PMC5613201          DOI: 10.3892/etm.2017.4907

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  30 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  A genome-wide association study identifies three new risk loci for Kawasaki disease.

Authors:  Yoshihiro Onouchi; Kouichi Ozaki; Jane C Burns; Chisato Shimizu; Masaru Terai; Hiromichi Hamada; Takafumi Honda; Hiroyuki Suzuki; Tomohiro Suenaga; Takashi Takeuchi; Norishige Yoshikawa; Yoichi Suzuki; Kumi Yasukawa; Ryota Ebata; Kouji Higashi; Tsutomu Saji; Yasushi Kemmotsu; Shinichi Takatsuki; Kazunobu Ouchi; Fumio Kishi; Tetsushi Yoshikawa; Toshiro Nagai; Kunihiro Hamamoto; Yoshitake Sato; Akihito Honda; Hironobu Kobayashi; Junichi Sato; Shoichi Shibuta; Masakazu Miyawaki; Ko Oishi; Hironobu Yamaga; Noriyuki Aoyagi; Seiji Iwahashi; Ritsuko Miyashita; Yuji Murata; Kumiko Sasago; Atsushi Takahashi; Naoyuki Kamatani; Michiaki Kubo; Tatsuhiko Tsunoda; Akira Hata; Yusuke Nakamura; Toshihiro Tanaka
Journal:  Nat Genet       Date:  2012-03-25       Impact factor: 38.330

Review 3.  Kawasaki disease: an update on diagnosis and treatment.

Authors:  Ho-Chang Kuo; Kuender D Yang; Wei-Chiao Chang; Luo-Ping Ger; Kai-Sheng Hsieh
Journal:  Pediatr Neonatol       Date:  2012-01-17       Impact factor: 2.083

4.  Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.

Authors:  Kimiyasu Egami; Hiromi Muta; Masahiro Ishii; Kenji Suda; Yoko Sugahara; Motofumi Iemura; Toyojiro Matsuishi
Journal:  J Pediatr       Date:  2006-08       Impact factor: 4.406

5.  Quantitative monitoring of gene expression patterns with a complementary DNA microarray.

Authors:  M Schena; D Shalon; R W Davis; P O Brown
Journal:  Science       Date:  1995-10-20       Impact factor: 47.728

Review 6.  Diagnosis and therapy of Kawasaki disease in children.

Authors:  A S Dajani; K A Taubert; M A Gerber; S T Shulman; P Ferrieri; M Freed; M Takahashi; F Z Bierman; A W Karchmer; W Wilson
Journal:  Circulation       Date:  1993-05       Impact factor: 29.690

7.  Resistance to intravenous immunoglobulin in children with Kawasaki disease.

Authors:  Adriana H Tremoulet; Brookie M Best; Sungchan Song; Susan Wang; Elena Corinaldesi; Julia R Eichenfield; Danielle D Martin; Jane W Newburger; Jane C Burns
Journal:  J Pediatr       Date:  2008-03-04       Impact factor: 4.406

8.  Chemokines in Kawasaki disease: measurement of CCL2, CCL22 and CXCL10.

Authors:  Yasufumi Shikishima; Toshiaki Saeki; Nobuo Matsuura
Journal:  Asian Pac J Allergy Immunol       Date:  2003-09       Impact factor: 2.310

9.  The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment.

Authors:  K Durongpisitkul; V J Gururaj; J M Park; C F Martin
Journal:  Pediatrics       Date:  1995-12       Impact factor: 7.124

10.  SDPR induces membrane curvature and functions in the formation of caveolae.

Authors:  Carsten G Hansen; Nicholas A Bright; Gillian Howard; Benjamin J Nichols
Journal:  Nat Cell Biol       Date:  2009-06-14       Impact factor: 28.824

View more
  2 in total

1.  Serum exosomal miR-328, miR-575, miR-134 and miR-671-5p as potential biomarkers for the diagnosis of Kawasaki disease and the prediction of therapeutic outcomes of intravenous immunoglobulin therapy.

Authors:  Xiaofei Zhang; Guangda Xin; Dajun Sun
Journal:  Exp Ther Med       Date:  2018-07-17       Impact factor: 2.447

2.  The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19.

Authors:  Camila Rosat Consiglio; Nicola Cotugno; Fabian Sardh; Christian Pou; Donato Amodio; Lucie Rodriguez; Ziyang Tan; Sonia Zicari; Alessandra Ruggiero; Giuseppe Rubens Pascucci; Veronica Santilli; Tessa Campbell; Yenan Bryceson; Daniel Eriksson; Jun Wang; Alessandra Marchesi; Tadepally Lakshmikanth; Andrea Campana; Alberto Villani; Paolo Rossi; Nils Landegren; Paolo Palma; Petter Brodin
Journal:  Cell       Date:  2020-09-06       Impact factor: 41.582

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.